Related Experiment Video
Updated: Jul 29, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
C-Abl is a nonreceptor tyrosine kinase that is tightly regulated in the cell. Genetic data derived from studies in flies and mice strongly support a role for Abl kinases in the regulation of the cytoskeleton (reviewed in [1,2]). C-Abl can be activated by several stimuli, including oxidative stress [3], DNA damage [4], integrin engagement [5], growth factors, and Src family kinases [6]. Structural alterations elicit constitutive activation of the c-Abl tyrosine kinase, leading to oncogenic transformation. While the mechanisms that activate c-Abl are beginning to be elucidated, little is known regarding the mechanisms that downregulate activated c-Abl. Here, we show for the first time that activated c-Abl is downregulated by the ubiquitin-dependent degradation pathway. Activated forms of c-Abl are more unstable than wild-type and kinase-inactive forms. Moreover, inhibition of the 26S proteasome leads to increased c-Abl levels in vitro and in cells, and activated c-Abl proteins are ubiquitinated in vivo. Significantly, inhibition of the 26S proteasome in fibroblasts increases the levels of tyrosine-phosphorylated, endogenous c-Abl. Our data suggest a novel mechanism for irreversible downregulation of activated c-Abl, which is critical to prevent the deleterious consequences of c-Abl hyperactivation in mitogenic and cytoskeletal pathways.
Insights
Activated c-Abl (Abelson murine leukemia virus oncogene homolog 1) is degraded via the ubiquitin-proteasome system. This pathway ensures downregulation of hyperactivated c-Abl, preventing oncogenic transformation and cytoskeletal pathway disruption.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- c-Abl is a nonreceptor tyrosine kinase crucial for cytoskeletal regulation.
- Dysregulation and constitutive activation of c-Abl can lead to oncogenic transformation.
- Mechanisms for downregulating activated c-Abl remain largely unknown.
Purpose of the Study:
- To investigate the mechanisms responsible for the downregulation of activated c-Abl.
- To determine if the ubiquitin-dependent degradation pathway plays a role in c-Abl regulation.
Main Methods:
- Assessing c-Abl protein stability under various conditions.
- Utilizing proteasome inhibition (26S proteasome) in vitro and in cell cultures.
- Examining c-Abl ubiquitination in vivo.
- Measuring tyrosine-phosphorylated endogenous c-Abl levels in fibroblasts.
Main Results:
- Activated c-Abl forms exhibit greater instability compared to wild-type or kinase-inactive forms.
- Inhibition of the 26S proteasome increases c-Abl levels.
- Activated c-Abl proteins undergo ubiquitination in vivo.
- Proteasome inhibition elevates tyrosine-phosphorylated endogenous c-Abl in fibroblasts.
Conclusions:
- Activated c-Abl is downregulated through the ubiquitin-dependent degradation pathway.
- This pathway provides a novel mechanism for irreversible downregulation of activated c-Abl.
- Effective downregulation is critical for preventing adverse effects of c-Abl hyperactivation on cellular pathways.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex
Export of Misfolded Proteins out of the ER
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome Structure
The proteasome is an...

